Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Delivery: Moving from Platform to Product

Apr 01 2003

• By Deborah Erickson

Related Content

Zars Inc.

Jun 01 2000

XenoPort Inc.

Sep 01 2001

Antibody Opportunities

Jan 01 2001

Opportunity Cost: How Alkermes Plans to Survive the Long Winter

Sep 01 2002

CellGate Inc.

Sep 01 1999

Related Companies

Johnson & Johnson

Johnson & Johnson

Allergan plc

Johnson & Johnson

Nektar Therapeutics

Nektar Therapeutics

Lavipharm Corp.

Lavipharm Group

Repros Therapeutics, Inc.

Alkermes plc

Stanford University

Sanofi

XenoPort, Inc.

Pfizer Inc.

Elan Corporation

Takeda Pharmaceutical Co. Ltd.

Bausch Health Companies Inc.

Synt:em SA

Boston Scientific Corporation

Vivoryon Therapeutics N.V.

Diatos SA

Institut Pasteur

OctoPlus N.V.

TBG Diagnostics Limited.

Biogen, Inc.

XOMA Royalty Corporation

University of Pittsburgh

University of Washington

Corium Inc.

MiddleBrook Pharmaceuticals

Crescita Therapeutics Inc.

Teva Pharmaceutical Industries Ltd.

Cephalon, Inc.

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window